Overview
Status
Active
Registry date
2021-07-05
Share capital
50,000.00 PLN
Registered address
ul. Balicka 99, 30-149 Kraków, Poland
Electronic delivery address
AE:PL-96102-88686-TFESI-26
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $4,949 |
Filing timeliness
1 of 5 financial statements was filed late (for 2021, 67 days late).
- 2025filed
- 202416/06/2025
- 202317/06/2024
- 202231/05/2023
- 202120/09/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 842.83kMedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD 108.51kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 727.97kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 192.25kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Alexander Fet'kovský – President of the Management Board
Magdalena Krystyna Parocka – Attorney-in-fact (sole)
Manner of representation
In the case of a multi-member management board, each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Alexander Fetkovský | 250 | $6,753.11 | 50% |
Sanaclis S.r.o. | 250 | $6,753.11 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-07-14.
85 1600 1462 1854 5164 7000 0001
04 1600 1462 1854 5164 7000 0004
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| SkinlabP.S.A. | $1,797,229.06 | skinlab.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org |
FAQ
The main business activity of Sanaclis Poland focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on July 5, 2021.
The headquarters is located at: ul. Balicka 99, 30-149 Kraków.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $467,011, representing an increase of 15.1% compared to 2023.
No, the company recorded a net loss of $50,628 in 2024.
The largest operating cost category falls under employee remuneration. This category amounted to $346,020 in 2024, representing 67% of all operating expenses.
Last updated: 2026-04-28